baber/WOPTO huggingface dataset:
Patent DE-235438-T1 (DE)
IPC: A47K10/34
Filed: 1986-10-02
Abstract: An apparatus for dispensing paper towels of predetermined length includes a case (1,2), a supply roll (8) of a continuous paper web (5), a mechanism (33, 35, 63) for advancing the paper web outside the case, a mechanism (85) for at least partially cutting the paper web protruding from the case, and a motor (64) for driving both mechanisms, the motor shaft being rotated in a first direction until a paper web of predetermined length is advanced outside the case and then reversed so that the paper advancement is stopped and the paper web is cut. A first unidirectional coupler (116,120,122) is arranged between the motor and the advancing mechanism and a second unidirectional coupler (115,110,112) is arranged between the motor and the cutting mechanism to selectively actuate either of the advancing or cutting mechanisms according to the rotational direction of the motor shaft. The length of the dispensed towel is an integral multiple of an elementary length and the number of elementary lengths by which the paper web is advanced before being cut is switch selectable. In one embodiment, the start-up circuit includes a photoelectric arrangement (53,54) affording non-contact type activation of the apparatus by a user, and in another embodiment, which is battery operated, includes a microswitch (53a) adapted for direct operation by a user.
Patent ES-2161200-T1 (ES)
Title: Concentrados liquidos decolorantes-fijadores unitarios.
Inventor: PAPAI LASZLO
IPC: G03C7/42
Filed: 2000-01-18
Abstract: Un concentrado líquido decolorante-fijador unitario siendo el concentrado activamente estable al almacenaje, caracterizado por ingredientes que comprenden: a) un agente decolorante que oxida plata metálica; y b) una combinación de agentes fijadores, comprendiendo por lo menos uno de dichos agentes fijadores una sal tiocianato presente en una cantidad eficaz para inhibir substancialmente la formación de cristales en el concentrado líquido decolorante-fijador unitario y para formar un concentrado líquido decolorante-fijador unitario activamente estable al almacenaje y adecuado para la dilución para dar una disolución de capacidad eficaz de trabajo.
Patent ES-2247959-T1 (ES)
Title: Formulacion medica en aerosol estabilizada en agua.
Inventor: ADJEI AKWETE
IPC: A61K31/58
Filed: 2003-09-03
Abstract: Una formulación médica en aerosol, que consiste esencialmente en: (a) una cantidad terapéuticamente eficaz de una combinación de al menos dos medicamentos diferentes en partículas, que no incluye un solvato de un compuesto de beclometasona; (b) un propelente; (c) opcionalmente, un codisolvente; y (d) un agente estabilizante que consiste en agua, además de agua naciente presente en la formulación, en una cantidad que oscila desde alrededor de 300 partes en peso hasta alrededor de 2000 partes en peso por un millón de partes en peso del peso total de la formulación
Patent ES-2055677-T1 (ES)
Title: Procedimiento de obtencion de una composicion para el tratamiento de la disfuncion erectil.
Inventor: KOCK NILS G
IPC: A61K31/5575
Filed: 1989-08-31
Abstract: COMPOSICION DE SUSTANCIA ACTIVA LIOFILA Y SU USO EN UN NUEVO METODO PARA TRATAR DISFUNCION ERECTIL POR ADMINISTRACION DE ELLA, OPCIONALMENTE JUNTO CON UN VEHICULO HIDROFILO Y OPCIONALMENTE UN AGENTE ANTIBACTERIANO DENTRO DE LA URETRA.
Patent ES-2049690-T1 (ES)
Inventor: BOMBARDELLI EZIO
IPC: A61K31/22
Filed: 1993-02-19
Abstract: The preparation of new 3,11-cyclotaxanes having the general formula 1. Cyclotaxane 1a (1, R'=R''=H) may be isolated from plants of the genus Taxus. New cyclotaxanes 1 have antiblastic activity.
Patent ES-2062962-T1 (ES)
Title: Dispositivo aplicador de fleje de zunchado.
Inventor: BARTZICK GERD
IPC: B65B13/22
Filed: 1994-02-09
Abstract: LA INVENCION SE REFIERE A UN DISPOSITIVO DE ZUNCHADO CON FLEJES CON UN CANAL (10) DE QUE RODEA LA PIEZA (11) A EMPACAR EN FORMA DE LAZO, ESTANDO MONTADA EN UNA DIRECCION DE DESPLAZAMIENTO, CONDUCCION Y SUJECION, CON ACCIONAMIENTO POR MEDIO DE UN MOTOR DE CORRIENTE GIRATORIA Y UN CONVERTIDOR (14) DE FRECUENCIA CONJUNTA A PARTIR DE LA CORRIENTE CON REFERENCIA A LA FRECUENCIA DE ESTA CORRIENTE PARA LA MODIFICACION DE LA VELOCIDAD DE GIRO DEL MOMENTO GIRATORIO Y CON CAMBIO DE LA POSICION DE FASE.
Patent ES-2120931-T1 (ES)
Inventor: SVEDMAN PAL
IPC: A61B5/00
Filed: 1994-12-01
Abstract: Apparatus (301) is disclosed for use in sampling transdermal perfusion exudate from a de-epithelialised skin erosion. The apparatus comprises an enclosure defining a sampling chamber (307), securing means (306) operable to sealingly secure a contact surface of the enclosure to an area of skin peripheral to the erosion and an aperture (6) defined in the contact surface and communicating with the sampling chamber. The apparatus also comprises an outlet (310) which communicates with the sampling chamber for the outflow of exudate, an openable closure (311) for the outlet and means (309) for applying suction to the sampling chamber to enhance the rate at which exudate is produced.
Patent CY-1109045-T1 (CY)
Title: Ρετινοειδη για τη θεραπεια του εμφυσηματος
Inventor: LAPIERRE JEAN-MARC
IPC: A61K31/505
Filed: 2009-01-22
Abstract: Η παρούσα ευρεσιτεχνία παρέχει πρωτότυπες ρετινοειδείς ενώσεις και μεθόδους σύνθεσης αυτών, τη χρήση τέτοιων ενώσεων για την παρασκευή φαρμάκων για τη θεραπεία ή την πρόληψη του εμφυσήματος, του καρκίνου και των δερματολογικών διαταραχών, μεθόδους για αυτές τις ασθένειες και φαρμακευτικές συνθέσεις κατάλληλες για τη θεραπεία ή την πρόληψη του εμφυσήματος, του καρκίνου και των δερματολογικών διαταραχών.
Patent CY-1109171-T1 (CY)
Inventor: EK FREDRIK
IPC: A61K31/553
Filed: 2009-06-25
Abstract: Disclosed herein are analogs of clozapine and pharmaceutically acceptable salts, esters, amides, or prodrugs thereof; methods of synthesizing the analogs; and methods of using the analogs for treating neuorpsychiatric disorders. In some embodiments, the analogs are amino substituted diaryl[a,d]cycloheptenes.
Patent CY-1109970-T1 (CY)
Inventor: OR YAT SUN
IPC: A61K31/7048
Filed: 2010-04-14
Abstract: The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
Patent CY-1111803-T1 (CY)
Inventor: TIMMERMAN PETER
IPC: G01N33/68
Filed: 2011-09-09
Abstract: The invention relates to the field of candidate drug testing and drug development. The invention provides a method for selecting a candidate drug compound from among a library of compounds wherein binding of a target molecule is determined with said candidate compound bound to a solid support and also is determined with said candidate compound not bound to a solid support said method comprising selecting said candidate compound from among compounds composed of an invariant scaffold molecule to which a variant potential binding site molecule is linked. Furthermore, the invention relates to methods for attaching molecules to a scaffold. In particular, the invention relates to the synthesis of discontinuous or conformational binding sites or epitopes corresponding to or interacting with a binding molecule, in particular in relation to protein-protein or protein-ligand interactions.
Patent CY-1114964-T1 (CY)
Title: Συστημα εισαγωγης υπερ-ψυχρου αερα και καυσιμου για μηχανες εσωτερικης καυσης
Inventor: BACH JEFF
IPC: F02D19/10
Filed: 2014-01-24
Abstract: Σύστημα που περιλαμβάνει μία κάψουλα (2) για την παρασκευή μιας προκαθορισμένης ποσότητας ροφήματος κατάλληλου για κατανάλωση χρησιμοποιώντας ένα προϊόν εκχύλισης που περιλαμβάνει: ένα ουσιαστικά άκαμπτο περιφερειακό τοίχωμα (6), ένα πυθμένα (7) που κλείνει το περιφερειακό τοίχωμα σε ένα πρώτο άκρο (8), και ένα καπάκι (9) που αποτελείται από ένα εύκαμπτο σε σχήμα φύλλου διάτρητο και/ ή πορώδες υλικό που κλείνει το περιφερειακό τοίχωμα σε ένα δεύτερο, ανοιχτό άκρο (10) απέναντι από τον πυθμένα, όπου το περιφερειακό τοίχωμα, ο πυθμένας και το καπάκι περικλείουν ένα εσωτερικό χώρο (11) που περιλαμβάνει το προϊόν εκχύλισης, όπου το καπάκι περιλαμβάνει μία στεγανή εξωτερική περιφερειακή περιοχή (30) και μία περιοχή εξόδου (32) που περικλείεται από την εν λόγω στεγανή εξωτερική περιφερειακή περιοχή έτσι ώστε κατά την χρήση, το παρασκευασμένο ρόφημα αδειάζει από την κάψουλα διαμέσου της περιοχής εξόδου. Η εφεύρεση περαιτέρω σχετίζεται με μία μέθοδο παρασκευής του εν λόγω ροφήματος χρησιμοποιώντας το παραπάνω σύστημα.
Patent CY-1115371-T1 (CY)
Title: Συνδεσμος λεκανης wc
Inventor: MCALPINE JAMES EDWARD
IPC: E03D11/16
Filed: 2014-06-30
Abstract: Σύνδεσμος λεκάνης WC (10) που περιλαμβάνει κέλυφος (12) που ορίζει διαμπερή οπή (14), που έχει είσοδο (16) προσαρμοσμένη για να συνδεθεί σε έξοδο (40) από WC, και έξοδο (18) προσαρμοσμένη για να συνδεθεί με είσοδο αγωγού αποχέτευσης (50). Ο σύνδεσμος (10) επίσης περιλαμβάνει στοιχείο στεγανοποίησης (20) για τον σχηματισμό στεγανότητας ανάμεσα στο κέλυφος (12) και την έξοδο του WC (40) και υποδοχή συγκράτησης του στοιχείου στεγανοποίησης (22) προσαρμοσμένη για να εμπλέξει τμήμα του στοιχείου στεγανοποίησης (20) και να διατηρήσει στοιχείο στεγανοποίησης (20) σε μια προτιμώμενη διαμόρφωση.
Patent CY-1117702-T1 (CY)
Title: Πρωτεϊνες δεσμευομενες με αντιγονο ικανες να δεσμευονται με θυμικη στρωματικη λεμφοποιητινη
Inventor: COMEAU MICHAEL R
IPC: C07K16/24
Filed: 2016-06-29
Abstract: Η παρούσα γνωστοποίηση παρέχει συνθέσεις και μεθόδους που σχετίζονται με πρωτεΐνες δεσμευόμενες με αντιγόνο οι οποίες δεσμεύονται με ανθρώπινη θυμική στρωματική λεμφοποιητίνη (TSLP), συμπεριλαμβανομένων αντισωμάτων. Σε συγκεκριμένες υλοποιήσεις, η γνωστοποίηση παρέχει πλήρως ανθρώπινα, ανθρωποποιημένα και χιμαιρικά αντισώματα αντι-TSLP και παράγωγα τέτοιων αντισωμάτων. Η γνωστοποίηση παρέχει επιπλέον νουκλεϊκά οξέα που κωδικοποιούν τέτοια αντισώματα και θραύσματα και παράγωγα αντισωμάτων, και μεθόδους παραγωγής και χρήσης τέτοιων αντισωμάτων συμπεριλαμβανομένων μεθόδων θεραπευτικής και προληπτικής αγωγής TSLP-σχετιζόμενων φλεγμονωδών και ινωτικών διαταραχών.
Patent CY-1119539-T1 (CY)
Title: Πληρως ανθρωπινα αντισωματα ειδικα για to cadμ1
Inventor: TERRETT JONATHAN ALEXANDER
IPC: C07K16/30
Filed: 2017-08-29
Abstract: Η παρούσα περιγραφή παρέχει απομονωμένα μονοκλωνικά αντισώματα, συγκεκριμένα ανθρώπινα μονοκλωνικά αντισώματα, πιο συγκεκριμένα τροποποιημένα αντισώματα με συνέπεια την αυξημένη πρόσδεση στους υποδοχείς Fc ή/και την αυξημένη ισχύ για ADCC. ή ανοσοσυζεύγματα, που δεσμεύονται ειδικά στο CADMI με υψηλή συγγένεια. Παρέχονται επίσης μόρια νουκλεϊκού οξέος που κωδικοποιούν για τα CADMI αντισώματα, φορείς έκφρασης, κύτταρα ξενιστές και μέθοδοι για την έκφραση των αντισωμάτων. Επίσης παρέχονται μόρια διπλής ειδικότητας και φαρμακευτικές συνθέσεις που περιλαμβάνουν τα CADMI αντισώματα. Περιγράφονται μέθοδοι για την ανίχνευση του CADM1, καθώς και μέθοδοι για τη θεραπεία διάφορων καρκίνων, συμπεριλαμβανομένων των καρκίνων του πνεύμονα και του παγκρέατος.
Patent CY-1123586-T1 (CY)
Title: Υποδορια σκευασματα αντισωματος her2
Inventor: ENG-WONG JENNIFER
IPC: A61K39/395
Filed: 2020-11-23
Abstract: Παρέχονται σταθερής δόσης σκευάσματα αντισώματος HER2 για υποδόρια χορήγηση καθώς και η χρήση τους στη θεραπεία του καρκίνου. Τα σκευάσματα περιλαμβάνουν σταθερής δόσης υποδόρια σκευάσματα περτουζουμάμπης και υποδόρια συνδυασμένα σκευάσματα περτουζουμάμπης και τραστουζουμάμπης και τη χρήση τους στη θεραπεία του καρκίνου.
Patent HR-P20110230-T1 (HR)
Inventor: BESANA CLAUDIA
IPC: A61P25/32
Filed: 2011-03-30
Abstract: Upotreba spojeva, naznačena time da su odabrani od sljedećih: 2-(4-benziloksibenzilamino)propanamid, 2-[4-(2-metoksibenziloksi)-benzilamino]propanamid, 2-[4-(2-fluorbenziloksi)-benzilamino]propanamid, (S)-(+)-2-[4-(2-fluorbenziloksi)-benzilamino]propanamid, (S)-(+)-2-[4-(3-fluorbenziloksi)-benzilamino]propanamid, 2-[4-(2-fluorbenziloksi)-benzilamino]-2-metil-propanamid, 2-[4-(2-fluorbenziloksi)-benzilamino]-N-metil-propanamid, N-{2-[4-(2-fluorbenziloksi)-benzilamino]}propionil-pirolidin, 2-[4-(3-metoksibenziloksi)-benzilamino] propanamid, 2-[4-(3-cijanobenziloksi)-benzilamino]propanamid, 2-[4-(3-fluorbenziloksi)-benzilamino]propanamid, 2-[4-(3-fluorbenziloksi)-benzilamino]-2- metil-propanamid, 2-[4-(3-fluorbenziloksi)-benzilamino]-N- metil-propanamid, N-{2-[4-(3-fluorbenziloksi)-benzilamino]}propionil-pirolidin, 2-[4-(4-fluorbenziloksi)-benzilamino]propanamid, 2-[4-(3-fluorbenziloksi)-benzilamino]- 2- metilpropanamid, 2-[4-(2-klorbenziloksi)-benzilamino] propanamid, 2-[4-(3-klorbenziloksi)-benzilamino]propanamid, 2-(4-benziloksibenzilamino)-3-hidroksi-propanamid, 2-[4-(2-fluorbenziloksi)-benzilamino]-3-hidroksi-propanamid, 2-[4-(3-fluorbenziloksi)-benzilamino]-3-hidroksi-propanamid, 2-(4-benziloksibenzilamino)-3-hidroksi-N-metil-propanamid, 2-[4-(2-fluorbenziloksi)-benzilamino]-3-hidroksi-N-metil-propanamid, 2-[4-(3-fluorbenziloksi)-benzilamino]-3-hidroksi-N-metil-propanamid, 2-[4-(2-klorbenziloksi)-benzilamino]-3- hidroksi-N-metil-propanamid, 2-[4-(3-cijanobenziloksi)-benzilamino]-3-hidroksi-N-metil-propanamid, 2-[4-(3-cijanobenziloksi)-benzilamino]-2-metil-3-hidroksi-N-metil-propanamid, 2-[4-(3-klorbenziloksi)-feniletilamino]propanamid, 2-{4-[2-(3-fluorfenil)-etiloksi] benzilamino}propanamid, 2-{4-[2-(3-fluorfenil)-etil] benzilamino}propanamid, 2-[N-(4-benziloksibenzil)-N-metilamino]propanamid, 2-{4-[(3-klorbenziloksi)-feniletil]-amino}propanamid, 2-[4-benziltiobenzilamino]propanamid, 2-[4-(2-fluorbenziltio)-benzilamino]propanamid, 2-[4-(3-fluorbenziltio)-benzilamino]propanamid, 2-[4-(3-fenilpropiloksi)-benzilamino]propanamid, 2-[4-(4-fenilbutiloksi)-benzilamino]propanamid, 2-[4-(5-fenilpentiloksi)-benzilamino]propanamid2-(4-benziloksibenzilamino)-3-fenil-N-metil-propanamid, 2-(4-benziloksibenzilamino)-3-metil-N-metil-butanamid, 2-(4-benziloksibenzilamino)-2-fenil-acetamid, 2-[4-(2-fluorbenziloksi)-benzilamino]-2-fenil-acetamid, 2-[4-(3-fluorbenziloksi)-benzilamino]-2-fenil-acetamid, 2-[4-(2-fluorbenziloksi)-benzil-N-metilamino]-2-fenil-acetamid, 2-[4-(3-fluorbenziloksi)-benzil-N-metilamino]-2-fenil-acetamid, 2-[4-(3-klorbenziloksi)-benzilamino]-2-fenil-acetamid, 2-[4-(2-fluorbenziloksi)-benzilamino]- 2-(2-fluorfenil)-acetamid, 2-[4-(2-fluorbenziloksi)-benzilamino]- 2-(3-fluorfenil)-acetamid, 2-[4-(3-fluorbenziloksi)-benzilamino]- 2-(2-fluorfenil)-acetamid, 2-[4-(3-fluorbenziloksi)-benzilamino]- 2-(3-fluorfenil)-acetamid, 2-[4-(3-klorbenziloksi)-benzilamino]- 2-(3-fluorfenil)-acetamid, 2-(4-(2-tieniloksi)-benzilamino)propanamid, ili optički izo
Patent HR-P20120059-T1 (HR)
Inventor: SADELEER JOS WILLY GHISLAIN CORNEEL DE
IPC: A23L1/305
Filed: 2012-01-20
Abstract: Pripravak koji sadrži djelomično hidroliziranu bjelančevinu žitarice, naznačen time da 20% do 80% težinski, poželjno 25% do 70% težinski, djelomično hidrolizirane bjelančevine žitarice ima molekularnu težinu od 25 kDa ili veću, 8% težinski ili manje djelomično hidrolizirane bjelančevine žitarice ima molekularnu težinu od 1.4 kDa ili manju te time da djelomično hidrolizirana bjelančevina žitarice ima indeks topivosti dušika (NSI) od 90% ili veći, poželjno 95% ili veći kod pH 1 do 10. Patent sadrži još 11 patentnih zahtjeva.
Patent SI-1592423-T1 (SI)
Title: Combination therapy of zd6474 with 5-fu and/or cpt-11
Inventor: WEDGE STEPHEN ROBERT
IPC: A61P35/00
Filed: 2004-02-11
Abstract: The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human, which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises: the administration of ZD6474 in combination with 5-FU; ZD6474 in combination with CPT-11; or ZD6474 in combination with 5-FU and CPT-11.
Patent SI-1809663-T1 (SI)
Title: Method for purifying fsh
Inventor: VALAX PASCAL
IPC: A61K38/00
Filed: 2005-11-08
Abstract: The invention relates to a method for purifying recombinant human FSH or an FSH variant starting from crude FSH, comprising the following steps: 1) dye-affinity chromatography; 2) hydrophobic interaction chromatography; and 3) reverse phase chromatography.
Patent SI-1616592-T1 (SI)
Title: Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge for use with this inhaler
Inventor: HERDER MARTIN
IPC: A61M15/00
Filed: 2005-07-12
Abstract: In order to improve the security and reliability of administration of powdered pharmaceuticals through dry powder inhalers, the invention proposes an inhaler (1) for powdered medicaments, comprising an activating device (4) for manual engagement by the patient for repeatedly metering a dose of medicament to be administered to the patient, and further comprising an advancing mechanism (25) for advancing a counter or indexing means (8) each time the activating device (4) has been engaged by the patient so that a dose of medicament has been released for administration to the patient, wherein the counter or indexing means (8) comprises an index (9), the index (9) being detectable by a detection means (10) of the inhaler, and the detection means (10) being coupled to a locking mechanism (12), the locking mechanism (12) blocking the activating device (4) and/or any transportation mechanism (5) of the inhaler (1) delayed by a predetermined number of metering cycles since detection of the index (9), and a cartridge (3).
Patent SI-3404102-T1 (SI)
Title: Bone delivery conjugates and method of using same to target proteins to bone
Inventor: CRINE PHILIPPE
IPC: A61P19/00
Filed: 2005-04-21
Abstract: The invention relates to a pharmaceutical composition comprising a bone delivery conjugate having the structure Z-sALP-Y-Dn-X, wherein X is absent or is an amino acid sequence of at least one amino acid; Y is absent or is an amino acid sequence of at least one amino acid; Z is absent or is an amino acid sequence of at least one amino acid; Dn is a poly aspartate, wherein n=10 to 16; and sALP is a soluble alkaline phosphatase and uses thereof.
Patent SI-1948422-T1 (SI)
Title: Method and apparatus for manufacturing a wrap-around tube
Inventor: MULLER CHRISTIAN
IPC: B21D15/00
Filed: 2006-10-10
Abstract: In a method for manufacturing a wrap-around tube from at lest one strip-shaped material, the wrapping is brought about by at least one rotating wrapping element which is indirectly or directly in engagement with the wrap-around tube, and the strip-shaped material is wrapped onto a stationary wrapping core. An apparatus for manufacturing a wrap-around tube from at least one strip-shaped material is distinguished by the fact that it has a rotating wrapping element, which is indirectly or directly in engagement with the wrap-around tube, and a stationary wrapping core, onto which the at least one strip-shaped material is wrapped.
Patent SI-3025584-T1 (SI)
Title: Plant disease control composition and its use
Inventor: MATSUZAKI YUICHI
IPC: A01P3/00
Filed: 2014-07-15
Abstract: A composition for controlling plant diseases comprising a tetrazolinone compound represented by a formula (1): wherein n is an integer of any one of 0 to 5; R1 represents a halogen atom and the like; R2 represents a C1-C3 alkyl group and the like; the R1 or R2 can have independently halogen atom(s) in the alkyl moiety; with the proviso that when n is an integer of 2 or more, two or more of the R1 may be different from each other, and an azole compound, preferably the composition for controlling plant diseases wherein a weight ratio of the tetrazolinone compound to the azole compound is that of the tetrazolinone compound/the azole compound=0.1/1 to 10/1, shows an excellent controlling efficacy on plant diseases.
Patent SI-3026208-T1 (SI)
Title: Unit for stacking slats on a support ladder with double crossbeams for the production of venetian blinds
Inventor: DALLAN SERGIO
IPC: E06B9/00
Filed: 2015-11-24
Abstract: The invention relates to a unit for stacking of slats on a support ladder for the production of Venetian blinds. Such a unit comprises means for divaricating 10 a pair of crossbeams T1,T2 on a positioning plane p at the height of an insertion plane m of a slat. The divaricating means comprise: -two distinct divaricating elements 11,12, each of which is sized so as to be inserted between a pair of crossbeams without substantially divaricating them; - an actuating device 20 that supports both divaricating elements and is suitable to allow them to assume alternately a first operating configuration, in which they are disposed close to, or alongside, each other, and at least one second operating configuration, in which they are moved away from each other. The actuating device is movable with respect to the insertion plane m and the positioning plane p so as to move the two divaricating elements together with each other between an engagement position, in which both the divaricating elements are incident the positioning plane, and at least one disengagement position, in which both divaricating elements are not incident the positioning plane.
Patent SI-3015128-T1 (SI)
Title: Self-orienting syringe and syringe interface
Inventor: TUCKER BARRY L
IPC: A61M37/00
Filed: 2015-10-28
Abstract: A syringe includes a barrel having a proximal end, a distal end, and a sidewall extending between the proximal end and the distal end along a longitudinal axis. At least one syringe retaining member protrudes radially outwardly relative to an outer surface of the sidewall. The at least one syringe retaining member tapers axially in a direction from the distal end toward the proximal end. The at least one syringe retaining member is configured for selective engagement with a locking mechanism on a fluid injector to releasably lock the syringe with the fluid injector. A taper of the at least one syringe retaining member is configured to rotationally guide the syringe into alignment with the locking mechanism.
Patent TR-200603434-T1 (TR)
Title: Bir soğutucu ve kontrol yöntemi.
Inventor: ARISOY EMRE
IPC: F25D21/00
Filed: 2004-12-15
Abstract: Bu buluş, elektrik dağıtım şirketleri tarafından belirlenen ucuz elektrik tüketim tarifesine göre defrost ünitesinin (4) sabit veya değişken algoritmalarla önceden belirlenmiş çalışma zamanları değiştirilerek ucuz tarife diliminde daha çok sayıda, pahalı tarife diliminde ise daha az sayıda defrost işlemi yapan, böylece kullanıcıya yansıyan elektrik tüketim maliyetinin azalmasını sağlayan bir soğutucu (1) ile ilgilidir.
Patent DE-3686200-T2 (DE)
Inventor: SCHALLY ANDREW V
IPC: C07K14/655
Filed: 1986-04-15
Granted: 1993-03-11
Abstract: Novel compositions of the formulawhereinA represents an L, D or DL amino-acid selected from the group consisting of Ala, Val, Phe, p-CI-Phe, Trp, Pro, Ser, Thr, Glu, Gly, Beta Ala, Abu, N-Me Ala, 5-F-Trp, 5-Br-Trp, 5-Cl-Trp, their acetylated derivatives or a pharmaceutically acceptable acid addition salt thereof;B represents an L, D or DL amino acid amide selected from the group consisting of Thr NH<sub>2</sub>, Val NH,, Pro NH<sub>2</sub>, HO-Pro NH<sub>2</sub>, Ser NH<sub>2</sub>, Tyr NH2, Trp NH<sub>2</sub>, 5-F-Trp NH,, For-Trp NH., Ala NH<sub>2</sub>, Gly NH2, Me Ala NH<sub>2</sub>;X represents L-Phe or L-Tyr,Y represents L-Thr or L-Val;Z is L, D or DL-5-F-Trp, 5-Br-Trp, 5-C1-Trp, 5-I-Trp or D-Trp; andC" and C' represent L or D Cys, Abu, Asp or Lys; provided that where C' is Cys, C" is also Cys and where C' or C" are other than Cys, C" is different from C' and is other than Cys and the pharmaceutically acceptable acid addition salts thereof; are useful as agents for inhibiting the release of growth hormone, for the treatment of gastrointestinal disorders and for therapy of certain cancers and the management of diabetes. These biologically active octapeptides all possess a terminal amino acid amide at position 8 and are prepared by solid phase methods.